TRIM25 and hepatocellular carcinoma: These results confirmed that lncRNA XIST could up-regulate the expression of TRIM25 by targeting and binding to miR-192, thus accelerating the occurrence and development of HBV-related HCC, which provided certain theoretical basis for targeted treatment of HBV-related HCC.